Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Determinants of the Thoracic Fluid Content Measured by the Bioimpedance-based Starling System in Critically Ill Patients

NCT05676723 is registered in ClinicalTrials.gov with Bicetre Hospital as lead sponsor.

NCT NCT05676723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05676723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Determinants of the Thoracic Fluid Content Measured by the Bioimpedance-based Starling System in Critically Ill Patients
Lead sponsor
Bicetre Hospital
Phase
Observational
Overall status
Completed
Start date
January 18, 2022
Completion date
November 2, 2022
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, fluid overload pulmonary edema, hemodynamic instability, shock